Clinical Trial: Effects of Acute and Chronic Empagliflozin Heart Failure
Study Status: Completed
Recruit Status: RECRUITING
Condition: Heart Failure
Study Type: INTERVENTIONAL
Official Title: Renal Mechanistic Effects of Acute and Chronic Empagliflozin in Heart Failure
Brief Summary:
This is a 60-patient randomized, double-blind, placebo-controlled mechanistic study to understand the utility of empagliflozin in worsening heart failure (HF) patients with or without diabetes.Participants will be randomized to empagliflozin or placebo for 6 weeks, followed by a crossover of placebo patients to active therapy at 6 weeks-12 weeks.
Read more